Not logged in
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
SaveLongitudinal ctDNA levels and clinical outcomes of first-line (1L) tislelizumab (TIS) plus chemotherapy (chemo) treatment for advanced non-small cell lung cancer (NSCLC) in the RATIONALE-304 and 307 studies
Lu, Shun; Wang, Jie; Sun, Meili; Zhao, Jun; Hu, Chunhong; Wang, Mengzhao; Zhou, Jianying; Song, Yong; Zhou, Qinghua; Zhang, Jiayuan; Shi, Yang; Huang, Ruiqi; Wu, Xikun; He, Wanyu; Qu, Xiaofei; Zhang, Yun; Shen, Zhirong; Yu, Yan
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save